Author: Shane Darke
Publisher:
ISBN: 9781912141111
Category :
Languages : en
Pages : 268
Book Description
The Clinician's Guide to Illicit Drugs and Health
Author: Shane Darke
Publisher:
ISBN: 9781912141111
Category :
Languages : en
Pages : 268
Book Description
Publisher:
ISBN: 9781912141111
Category :
Languages : en
Pages : 268
Book Description
Club Drugs and Novel Psychoactive Substances
Author: Owen Bowden-Jones
Publisher: Cambridge University Press
ISBN: 1911623095
Category : Medical
Languages : en
Pages : 141
Book Description
Emerging illicit drugs pose a significant clinical challenge. This handbook offers an engaging, concise guide to managing these challenges.
Publisher: Cambridge University Press
ISBN: 1911623095
Category : Medical
Languages : en
Pages : 141
Book Description
Emerging illicit drugs pose a significant clinical challenge. This handbook offers an engaging, concise guide to managing these challenges.
A Guide to Substance Abuse Services for Primary Care Clinicians
Author: Eleanor J. Sullivan
Publisher:
ISBN:
Category : Primary care (Medicine)
Languages : en
Pages : 194
Book Description
EXECUTIVE SUMMARY AND RECOMMENDATIONS: The goal of this TIP is to recommend guidelines for primary care clinicians to follow in caring for patients with alcohol and other drug use disorders. These guidelines were developed by a Consensus Panel of clinicians, researchers, and educators who work on the prevention and treatment of substance use disorders. Protocols are based partly on research evidence, partly on Panel members' clinical experience. The algorithm to the left follows a patient with substance use problems who presents in a primary care setting. The chart will serve as a guide or road map through screening, brief assessment, brief intervention, assessment, referral, specialized treatment, and followup care as they are detailed in the TIP. Since substance use disorders are often chronic conditions that progress slowly over time, primary care clinicians, through their regular, long-term contact with patients, are in an ideal position to screen for alcohol and drug problems and monitor each patient's status. Futhermore, studies have found that primary care clinicians can actually help many patients decrease alcohol consumption and its harmful consequences through office-based interventions that take only 10 to 15 minutes (Kahan et al., 1995; Wallace et al., 1988). This potential, however, is largely untapped: Saitz and colleagues found that of a sample of patients seeking substance abuse treatment, 45 percent reported that their primary care physician was unaware of their substance abuse (Saitz et al., in press). Yet even though screening and limited treatment of substance use disorders do not require a large time investment, the Consensus Panel that developed this TIP recognized that many primary care clinicians are already overwhelmed by the demands imposed by expanded gatekeeper functions. The Panel realized that a practical approach to addressing patients' substance abuse problems was needed: one that recognized the time and resource limitations inherent in primary care practice and offered a series of graduates approaches that could be incorporated into a normal clinic or office routine. Biological, medical, and genetic factors as well as psychological, social, familial, cultural, and other environmental features all bear on substance abuse. Addressing the condition effectively requires a team effort, especially when it has progressed beyond the early stage. For this reason, in addition to screening and intervention treatment options, these guidelines include information about viable referral for assessment and treatment, as well as followup. Readers will notice that the TIP contains more information on alcohol use and abuse than on use of illicit drugs. This reflects both the scope of the problems and the research literature available about them. It is estimated that about 18 million people with alcohol use problems and 5 million users of illicit drugs need treatment. Although the Panel recognizes that tobacco is an addictive substance with a major public health impact, it is not included in this TIP because the topic falls outside CSAT's purview. Readers are referred to "Smoking Cessation: a Guide for Primary Care Clinicians," published by the Agency for Health Care Policy and Research (Agency for Health Care Policy and Research, 1996). The Consensus Panel's recommendations are based on a combination of clinical experience and research-based evidence. In the list below, the summary guidelines supported by the research literature are followed by (1); clinically based recommendations are marked (2). Citations supporting the former are referenced in the body of the document. Screening and assessment instruments mentioned below are reproduced and discussed in Chapters 2 and 4 and Appendix C. The guidelines are presented in more detail in Chapter 6.
Publisher:
ISBN:
Category : Primary care (Medicine)
Languages : en
Pages : 194
Book Description
EXECUTIVE SUMMARY AND RECOMMENDATIONS: The goal of this TIP is to recommend guidelines for primary care clinicians to follow in caring for patients with alcohol and other drug use disorders. These guidelines were developed by a Consensus Panel of clinicians, researchers, and educators who work on the prevention and treatment of substance use disorders. Protocols are based partly on research evidence, partly on Panel members' clinical experience. The algorithm to the left follows a patient with substance use problems who presents in a primary care setting. The chart will serve as a guide or road map through screening, brief assessment, brief intervention, assessment, referral, specialized treatment, and followup care as they are detailed in the TIP. Since substance use disorders are often chronic conditions that progress slowly over time, primary care clinicians, through their regular, long-term contact with patients, are in an ideal position to screen for alcohol and drug problems and monitor each patient's status. Futhermore, studies have found that primary care clinicians can actually help many patients decrease alcohol consumption and its harmful consequences through office-based interventions that take only 10 to 15 minutes (Kahan et al., 1995; Wallace et al., 1988). This potential, however, is largely untapped: Saitz and colleagues found that of a sample of patients seeking substance abuse treatment, 45 percent reported that their primary care physician was unaware of their substance abuse (Saitz et al., in press). Yet even though screening and limited treatment of substance use disorders do not require a large time investment, the Consensus Panel that developed this TIP recognized that many primary care clinicians are already overwhelmed by the demands imposed by expanded gatekeeper functions. The Panel realized that a practical approach to addressing patients' substance abuse problems was needed: one that recognized the time and resource limitations inherent in primary care practice and offered a series of graduates approaches that could be incorporated into a normal clinic or office routine. Biological, medical, and genetic factors as well as psychological, social, familial, cultural, and other environmental features all bear on substance abuse. Addressing the condition effectively requires a team effort, especially when it has progressed beyond the early stage. For this reason, in addition to screening and intervention treatment options, these guidelines include information about viable referral for assessment and treatment, as well as followup. Readers will notice that the TIP contains more information on alcohol use and abuse than on use of illicit drugs. This reflects both the scope of the problems and the research literature available about them. It is estimated that about 18 million people with alcohol use problems and 5 million users of illicit drugs need treatment. Although the Panel recognizes that tobacco is an addictive substance with a major public health impact, it is not included in this TIP because the topic falls outside CSAT's purview. Readers are referred to "Smoking Cessation: a Guide for Primary Care Clinicians," published by the Agency for Health Care Policy and Research (Agency for Health Care Policy and Research, 1996). The Consensus Panel's recommendations are based on a combination of clinical experience and research-based evidence. In the list below, the summary guidelines supported by the research literature are followed by (1); clinically based recommendations are marked (2). Citations supporting the former are referenced in the body of the document. Screening and assessment instruments mentioned below are reproduced and discussed in Chapters 2 and 4 and Appendix C. The guidelines are presented in more detail in Chapter 6.
The National Treatment Improvement Evaluation Study, NTIES.
Novel Psychoactive Substances
Author: Paul I. Dargan
Publisher: Academic Press
ISBN: 0128190302
Category : Medical
Languages : en
Pages : 556
Book Description
Novel Psychoactive Substances: Classification, Pharmacology and Toxicology, Second Edition provides readers with a comprehensive examination on the classification, detection, supply and availability of novel psychoactive substances, otherwise known as "legal highs." The book covers individual classes of novel psychoactive substances that have recently emerged onto the recreational drug scene and provides an overview of the pharmacology of the substance and a discussion of their associated acute and chronic harm and toxicity. This second edition addresses drugs new to the scene, with completely updated and revised chapters. Written by international experts in the field, this multi-authored book is an essential reference for scientists, clinicians, academics, and regulatory and law enforcement professionals. - Includes chapters written by international experts in the field - Presents a comprehensive overview on the classification, detection, availability and supply of novel psychoactive substances, in addition to the pharmacology and toxicology associated with the substance - Offers a single source for all interested parties working in this area, including scientists, academics, clinicians, law enforcement and regulatory agencies - Provides a full treatment of novel psychoactive substances that have recently emerged onto the recreational drug scene, including amphetamines and the synthetic cannabinoid receptors in 'spice' and 'K2'
Publisher: Academic Press
ISBN: 0128190302
Category : Medical
Languages : en
Pages : 556
Book Description
Novel Psychoactive Substances: Classification, Pharmacology and Toxicology, Second Edition provides readers with a comprehensive examination on the classification, detection, supply and availability of novel psychoactive substances, otherwise known as "legal highs." The book covers individual classes of novel psychoactive substances that have recently emerged onto the recreational drug scene and provides an overview of the pharmacology of the substance and a discussion of their associated acute and chronic harm and toxicity. This second edition addresses drugs new to the scene, with completely updated and revised chapters. Written by international experts in the field, this multi-authored book is an essential reference for scientists, clinicians, academics, and regulatory and law enforcement professionals. - Includes chapters written by international experts in the field - Presents a comprehensive overview on the classification, detection, availability and supply of novel psychoactive substances, in addition to the pharmacology and toxicology associated with the substance - Offers a single source for all interested parties working in this area, including scientists, academics, clinicians, law enforcement and regulatory agencies - Provides a full treatment of novel psychoactive substances that have recently emerged onto the recreational drug scene, including amphetamines and the synthetic cannabinoid receptors in 'spice' and 'K2'
Handbook of Assessment and Treatment Planning for Psychological Disorders
Author: Martin M. Antony
Publisher: Guilford Publications
ISBN: 1462544886
Category : Medical
Languages : en
Pages : 658
Book Description
This authoritative clinical reference and text--now revised and updated with 50% new content--presents the assessment tools and strategies that every evidence-based psychotherapy practitioner needs. Unlike most assessment texts, the volume is organized around specific clinical problems. It explains how to select and use the best measures to assess clients' symptoms, generate diagnoses, plan appropriate treatments, and monitor progress. Clinician- and student-friendly features include tables comparing and contrasting relevant measures, sample forms, and case examples. Every chapter addresses considerations for primary and managed care settings. New to This Edition *Chapters on new topics: assessment of well-being and transdiagnostic assessment. *New chapters on core topics: eating disorders, personality disorders, and insomnia. *Updated throughout with DSM-5 diagnostic changes, new and updated instruments, current research, and increased attention to transdiagnostic concerns. *Expanded coverage of obsessive–compulsive and related disorders. See also Clinical Handbook of Psychological Disorders, Sixth Edition, edited by David H. Barlow, which presents evidence-based treatments step by step.
Publisher: Guilford Publications
ISBN: 1462544886
Category : Medical
Languages : en
Pages : 658
Book Description
This authoritative clinical reference and text--now revised and updated with 50% new content--presents the assessment tools and strategies that every evidence-based psychotherapy practitioner needs. Unlike most assessment texts, the volume is organized around specific clinical problems. It explains how to select and use the best measures to assess clients' symptoms, generate diagnoses, plan appropriate treatments, and monitor progress. Clinician- and student-friendly features include tables comparing and contrasting relevant measures, sample forms, and case examples. Every chapter addresses considerations for primary and managed care settings. New to This Edition *Chapters on new topics: assessment of well-being and transdiagnostic assessment. *New chapters on core topics: eating disorders, personality disorders, and insomnia. *Updated throughout with DSM-5 diagnostic changes, new and updated instruments, current research, and increased attention to transdiagnostic concerns. *Expanded coverage of obsessive–compulsive and related disorders. See also Clinical Handbook of Psychological Disorders, Sixth Edition, edited by David H. Barlow, which presents evidence-based treatments step by step.
Handbook of Drug Interactions
Author: Ashraf Mozayani
Publisher: Springer Science & Business Media
ISBN: 1592596541
Category : Medical
Languages : en
Pages : 662
Book Description
A concise compilation of the known interactions of the most commonly prescribed drugs, as well as their interaction with nonprescription compounds. The agents covered include CNS drugs, cardiovascular drugs, antibiotics, and NSAIDs. For each class of drugs the authors review the pharmacology, pharmacodynamics, pharmacokinetics, chemistry, metabolism, epidemiological occurrences, adverse reactions, and significant interactions. Environmental and social pharmacological issues are also addressed in chapters on food and alcohol drug interactions, nicotine and tobacco, and anabolic doping agents. Comprehensive and easy-to-use, Handbook of Drug Interactions: A Clinical and Forensic Guide provides physicians with all the information needed to avoid prescribing drugs with undesirable interactions, and toxicologists with all the data necessary to interpret possible interactions between drugs found simultaneously in patient samples.
Publisher: Springer Science & Business Media
ISBN: 1592596541
Category : Medical
Languages : en
Pages : 662
Book Description
A concise compilation of the known interactions of the most commonly prescribed drugs, as well as their interaction with nonprescription compounds. The agents covered include CNS drugs, cardiovascular drugs, antibiotics, and NSAIDs. For each class of drugs the authors review the pharmacology, pharmacodynamics, pharmacokinetics, chemistry, metabolism, epidemiological occurrences, adverse reactions, and significant interactions. Environmental and social pharmacological issues are also addressed in chapters on food and alcohol drug interactions, nicotine and tobacco, and anabolic doping agents. Comprehensive and easy-to-use, Handbook of Drug Interactions: A Clinical and Forensic Guide provides physicians with all the information needed to avoid prescribing drugs with undesirable interactions, and toxicologists with all the data necessary to interpret possible interactions between drugs found simultaneously in patient samples.
The Pocket Guide to Drugs and Health
Author: Julia Lappin
Publisher:
ISBN: 9781912141166
Category : Health & Fitness
Languages : en
Pages : 244
Book Description
The aim of our pocket guide is to provide "at a glance" key points for the busy clinician to access when dealing with a patient, presenting the pathologies pertinent to each drug, and options for the treatment of substance dependence. In the "The Pocket Guide to Drugs and Health" we have extended the drugs covered to include the major licit psychoactive drugs: alcohol, hypnosedatives, and nicotine & tobacco. Each major drug class is examined individually (Alcohol, Cannabis, Hallucinogens, Hypnosedatives, Nicotine & tobacco, New Psychoactive Substances, Opioids, Psychostimulants). In each chapter we present information on withdrawal and dependence syndromes, toxicity, the effects upon major organ systems, and psychiatric morbidities. There are also dedicated chapters on the medical complications of injecting drug use, and the treatment of drug dependence. It is our hope that this book will form a core pocket guide for medical practitioners, physicians in training and nurses.
Publisher:
ISBN: 9781912141166
Category : Health & Fitness
Languages : en
Pages : 244
Book Description
The aim of our pocket guide is to provide "at a glance" key points for the busy clinician to access when dealing with a patient, presenting the pathologies pertinent to each drug, and options for the treatment of substance dependence. In the "The Pocket Guide to Drugs and Health" we have extended the drugs covered to include the major licit psychoactive drugs: alcohol, hypnosedatives, and nicotine & tobacco. Each major drug class is examined individually (Alcohol, Cannabis, Hallucinogens, Hypnosedatives, Nicotine & tobacco, New Psychoactive Substances, Opioids, Psychostimulants). In each chapter we present information on withdrawal and dependence syndromes, toxicity, the effects upon major organ systems, and psychiatric morbidities. There are also dedicated chapters on the medical complications of injecting drug use, and the treatment of drug dependence. It is our hope that this book will form a core pocket guide for medical practitioners, physicians in training and nurses.
Alcohol and Other Drug Screening of Hospitalized Trauma Patients
Author: Peter O. Rostenberg
Publisher:
ISBN:
Category : Hospital patients
Languages : en
Pages : 108
Book Description
Publisher:
ISBN:
Category : Hospital patients
Languages : en
Pages : 108
Book Description
Pagliaros' Comprehensive Guide to Drugs and Substances of Abuse
Author: Louis A. Pagliaro
Publisher: American Pharmacists Association (APhA)
ISBN: 9781582121314
Category : Law
Languages : en
Pages : 0
Book Description
The completely revised Pagliaros Comprehensive Guide to Drugs and Substances of Abuse includes more than 100 monographs11 of them newthat deal with each of the major drugs and substances of abuse used in North America, from acetone to zopiclone. Each monograph lists generic synonyms, brand or trade names, chemical names, street names, and pharmacologic classification and provides a brief overview of the drug or substance of abuse, with attention given to its source, history, and patterns of use. Key Features: Available dosage forms and common routes and methods of administration.
Publisher: American Pharmacists Association (APhA)
ISBN: 9781582121314
Category : Law
Languages : en
Pages : 0
Book Description
The completely revised Pagliaros Comprehensive Guide to Drugs and Substances of Abuse includes more than 100 monographs11 of them newthat deal with each of the major drugs and substances of abuse used in North America, from acetone to zopiclone. Each monograph lists generic synonyms, brand or trade names, chemical names, street names, and pharmacologic classification and provides a brief overview of the drug or substance of abuse, with attention given to its source, history, and patterns of use. Key Features: Available dosage forms and common routes and methods of administration.